October 21, 2021
The Chase Group is pleased to announce their continued partnership with Atsena Therapeutics after being retained to execute a search for an Associate Director/Director of Process Development to join this fast-growing and well-financed company developing ocular gene therapies. The successful candidate will lead and manage a team of process and analytical development scientists responsible for the development, optimization, and characterization of Atsena’s AAV manufacturing platform to supply the next generation AAV vectors supporting early and late-stage development programs. If you would like further details regarding this search or would like to learn how The Chase Group can assist your firm, please contact Moira Newbanks at: moira@chasegroup.com.
